vs
游戏驿站（GME）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
游戏驿站的季度营收约是Revvity的1.1倍（$821.0M vs $772.1M），Revvity净利率更高（12.7% vs 9.4%，领先3.3%），Revvity同比增速更快（5.9% vs -4.6%），Revvity自由现金流更多（$161.8M vs $107.0M），过去两年Revvity的营收复合增速更高（9.0% vs -32.3%）
游戏驿站（GameStop Corp.）是美国知名电子游戏、消费电子及游戏周边零售企业，总部位于得克萨斯州格雷普韦恩，是全球规模最大的电子游戏零售商。截至2025年2月，公司在美、加、澳及欧洲地区共运营3203家门店，旗下拥有EB Games、ThinkGeek等多个零售品牌，前身为1984年于达拉斯成立的Babbage's。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
GME vs RVTY — 直观对比
营收规模更大
GME
是对方的1.1倍
$772.1M
营收增速更快
RVTY
高出10.4%
-4.6%
净利率更高
RVTY
高出3.3%
9.4%
自由现金流更多
RVTY
多$54.8M
$107.0M
两年增速更快
RVTY
近两年复合增速
-32.3%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $821.0M | $772.1M |
| 净利润 | $77.1M | $98.4M |
| 毛利率 | 33.3% | — |
| 营业利润率 | 5.0% | 14.5% |
| 净利率 | 9.4% | 12.7% |
| 营收同比 | -4.6% | 5.9% |
| 净利润同比 | 343.1% | 3.9% |
| 每股收益（稀释后） | $0.13 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GMERVTY
| Q4 25 | $821.0M | $772.1M | ||
| Q3 25 | $972.2M | $698.9M | ||
| Q2 25 | $732.4M | $720.3M | ||
| Q1 25 | $1.3B | $664.8M | ||
| Q4 24 | $860.3M | $729.4M | ||
| Q3 24 | $798.3M | $684.0M | ||
| Q2 24 | $881.8M | $691.7M | ||
| Q1 24 | $1.8B | $649.9M |
净利润GMERVTY
| Q4 25 | $77.1M | $98.4M | ||
| Q3 25 | $168.6M | $46.7M | ||
| Q2 25 | $44.8M | $53.9M | ||
| Q1 25 | $131.4M | $42.2M | ||
| Q4 24 | $17.4M | $94.6M | ||
| Q3 24 | $14.8M | $94.4M | ||
| Q2 24 | $-32.3M | $55.4M | ||
| Q1 24 | $63.1M | $26.0M |
毛利率GMERVTY
| Q4 25 | 33.3% | — | ||
| Q3 25 | 29.1% | 53.6% | ||
| Q2 25 | 34.5% | 54.5% | ||
| Q1 25 | 28.3% | 56.5% | ||
| Q4 24 | 29.9% | — | ||
| Q3 24 | 31.2% | 56.3% | ||
| Q2 24 | 27.7% | 55.7% | ||
| Q1 24 | 23.4% | 54.6% |
营业利润率GMERVTY
| Q4 25 | 5.0% | 14.5% | ||
| Q3 25 | 6.8% | 11.7% | ||
| Q2 25 | -1.5% | 12.6% | ||
| Q1 25 | 6.2% | 10.9% | ||
| Q4 24 | -3.9% | 16.3% | ||
| Q3 24 | -2.8% | 14.3% | ||
| Q2 24 | -5.7% | 12.4% | ||
| Q1 24 | 3.1% | 6.8% |
净利率GMERVTY
| Q4 25 | 9.4% | 12.7% | ||
| Q3 25 | 17.3% | 6.7% | ||
| Q2 25 | 6.1% | 7.5% | ||
| Q1 25 | 10.2% | 6.4% | ||
| Q4 24 | 2.0% | 13.0% | ||
| Q3 24 | 1.9% | 13.8% | ||
| Q2 24 | -3.7% | 8.0% | ||
| Q1 24 | 3.5% | 4.0% |
每股收益（稀释后）GMERVTY
| Q4 25 | $0.13 | $0.86 | ||
| Q3 25 | $0.31 | $0.40 | ||
| Q2 25 | $0.09 | $0.46 | ||
| Q1 25 | $0.36 | $0.35 | ||
| Q4 24 | $0.04 | $0.77 | ||
| Q3 24 | $0.04 | $0.77 | ||
| Q2 24 | $-0.11 | $0.45 | ||
| Q1 24 | $0.21 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.8B | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $5.3B | $7.3B |
| 总资产 | $10.6B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GMERVTY
| Q4 25 | $8.8B | $919.9M | ||
| Q3 25 | $8.7B | $931.4M | ||
| Q2 25 | $6.4B | $991.8M | ||
| Q1 25 | $4.8B | $1.1B | ||
| Q4 24 | $4.6B | $1.2B | ||
| Q3 24 | $4.2B | $1.2B | ||
| Q2 24 | $1.1B | $2.0B | ||
| Q1 24 | $1.2B | $1.7B |
总债务GMERVTY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $16.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $28.5M | — |
股东权益GMERVTY
| Q4 25 | $5.3B | $7.3B | ||
| Q3 25 | $5.2B | $7.4B | ||
| Q2 25 | $5.0B | $7.6B | ||
| Q1 25 | $4.9B | $7.6B | ||
| Q4 24 | $4.8B | $7.7B | ||
| Q3 24 | $4.4B | $7.9B | ||
| Q2 24 | $1.3B | $7.9B | ||
| Q1 24 | $1.3B | $7.8B |
总资产GMERVTY
| Q4 25 | $10.6B | $12.2B | ||
| Q3 25 | $10.3B | $12.1B | ||
| Q2 25 | $7.5B | $12.4B | ||
| Q1 25 | $5.9B | $12.4B | ||
| Q4 24 | $6.2B | $12.4B | ||
| Q3 24 | $5.5B | $12.8B | ||
| Q2 24 | $2.6B | $13.4B | ||
| Q1 24 | $2.7B | $13.4B |
负债/权益比GMERVTY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.02× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $111.3M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $107.0M | $161.8M |
| 自由现金流率自由现金流/营收 | 13.0% | 21.0% |
| 资本支出强度资本支出/营收 | 0.5% | 2.6% |
| 现金转化率经营现金流/净利润 | 1.44× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $568.7M | $509.4M |
8季度趋势，按日历期对齐
经营现金流GMERVTY
| Q4 25 | $111.3M | $182.0M | ||
| Q3 25 | $117.4M | $138.5M | ||
| Q2 25 | $192.5M | $134.3M | ||
| Q1 25 | $162.3M | $128.2M | ||
| Q4 24 | $24.6M | $174.2M | ||
| Q3 24 | $68.6M | $147.9M | ||
| Q2 24 | $-109.8M | $158.6M | ||
| Q1 24 | $-11.0M | $147.6M |
自由现金流GMERVTY
| Q4 25 | $107.0M | $161.8M | ||
| Q3 25 | $113.3M | $120.0M | ||
| Q2 25 | $189.6M | $115.5M | ||
| Q1 25 | $158.8M | $112.2M | ||
| Q4 24 | $20.0M | $149.8M | ||
| Q3 24 | $65.5M | $125.6M | ||
| Q2 24 | $-114.7M | $136.6M | ||
| Q1 24 | $-18.7M | $129.7M |
自由现金流率GMERVTY
| Q4 25 | 13.0% | 21.0% | ||
| Q3 25 | 11.7% | 17.2% | ||
| Q2 25 | 25.9% | 16.0% | ||
| Q1 25 | 12.4% | 16.9% | ||
| Q4 24 | 2.3% | 20.5% | ||
| Q3 24 | 8.2% | 18.4% | ||
| Q2 24 | -13.0% | 19.7% | ||
| Q1 24 | -1.0% | 20.0% |
资本支出强度GMERVTY
| Q4 25 | 0.5% | 2.6% | ||
| Q3 25 | 0.4% | 2.6% | ||
| Q2 25 | 0.4% | 2.6% | ||
| Q1 25 | 0.3% | 2.4% | ||
| Q4 24 | 0.5% | 3.4% | ||
| Q3 24 | 0.4% | 3.3% | ||
| Q2 24 | 0.6% | 3.2% | ||
| Q1 24 | 0.4% | 2.7% |
现金转化率GMERVTY
| Q4 25 | 1.44× | 1.85× | ||
| Q3 25 | 0.70× | 2.97× | ||
| Q2 25 | 4.30× | 2.49× | ||
| Q1 25 | 1.24× | 3.03× | ||
| Q4 24 | 1.41× | 1.84× | ||
| Q3 24 | 4.64× | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | -0.17× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GME
| Hardware And Accessories | $367.4M | 45% |
| Collectibles | $256.1M | 31% |
| Software | $197.5M | 24% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
